Skip to main content
. Author manuscript; available in PMC: 2020 Feb 20.
Published in final edited form as: Curr Cancer Drug Targets. 2019;19(5):417–427. doi: 10.2174/1568009618666180430123939

Fig. (9).

Fig. (9).

Bazedoxifene, SC144 and evista inhibit the colony forming ability in human pancreatic cancer cells. HPAC, Capan-1, BxPC-3 and MIA PaCa-2 cells were treated with bazedoxifene (0, 10 and 15 μM), SC144 (0, 10 and 15 μM) or evista (0, 10 and 15 μM) for 16 hours, then cells were harvested and reseeded on 6-cm plates with a drug-free medium for an additional incubation of 2 weeks. Colonies were fixed with methanol and stained with crystal violet dye (0.1% w/v). B: bazedoxifene.